文献速递肝病消化道肿瘤与早癌消化内镜

慢性丙型肝炎患者Gd-EOB-DTPA增强MRI上非富血供低信号结节的出现

The emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C.
PubMed 文献 · Aliment Pharmacol Ther · 2019-10-06

本研究对608例无HCC病史的慢性HCV感染患者行EOB-MRI,基线NHHN检出率为15.3%;515例基线无NHHN者1、3、5年NHHN累积出现率分别为1.8%、9.8%、16.4%,多因素分析仅FIB-4指数与NHHN出现独立相关。

要点

  • 慢性HCV感染者基线EOB-MRI的NHHN检出率为15.3%。
  • 基线无NHHN者5年NHHN出现率为16.4%。
  • FIB-4≥3.25者5年NHHN出现率24.1%,FIB-4<1.45者为0%。

核心结论

  • 在慢性HCV感染患者中,进展期肝纤维化是NHHN存在或出现的重要危险因素。

研究设计与样本

  • 纵向随访研究,纳入608例无HCC病史的慢性HCV感染患者行EOB-MRI检查。
  • 比较有无NHHN患者的特征,并在515例基线无NHHN者中分析NHHN出现率及危险因素。

主要发现

  • 基线时93/608例(15.3%)检出NHHN。
  • 515例基线无NHHN者1年、3年、5年NHHN出现率分别为1.8%、9.8%、16.4%。
  • 多因素分析仅FIB-4指数与NHHN出现独立相关。
  • FIB-4≥3.25者5年NHHN出现率为24.1%,FIB-4<1.45者为0%。

关键数值与推荐

  • FIB-4指数≥3.25的患者5年NHHN出现率为24.1%。
  • FIB-4指数<1.45的患者5年NHHN出现率为0%。

临床怎么用

  • 对慢性HCV感染患者可依据FIB-4指数分层评估NHHN发生风险。
  • 高FIB-4指数患者可能需要更密切的EOB-MRI随访以监测NHHN出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrahepatic non-hypervascular hypointense nodules (NHHNs) detected during the hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) have the potential to transition into typical hypervascular hepatocellular carcinoma (HCC). However, the incidence and risk factors for the emergence of these nodules in patients with chronic hepatitis C virus (HCV) infection are unknown. AIM: To investigate the incidence and risk factors for NHHNs in patients with chronic HCV infection in a longitudinal follow-up study METHODS: EOB-MRI was performed in 608 patients with chronic HCV infection and no history of HCC. The characteristics of patients with and without NHHNs were compared. In patients without NHHNs at baseline, the incidence of NHHN emergence and associated risk factors were analysed. RESULTS: NHHNs were detected at baseline in 93 of 608 patients (15.3%). Among 515 patients without NHHNs at baseline, the 1-year, 3-year and 5-year incidence of NHHN emergence was 1.8%, 9.8% and 16.4%, respectively. Only FIB-4 index was independently associated with the emergence of NHHNs in multivariate analyses. Whereas NHHNs emerged in 24.1% of patients with FIB-4 index ≥ 3.25 at 5 years, none emerged in patients with FIB-4 index < 1.45. CONCLUSION: In patients with chronic HCV infection, advanced liver fibrosis is an important risk factor for the presence or emergence of NHHNs.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Toyoda H, Tada T, Yasuda S, et al. The emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2019. PMID: 31588590. doi:10.1111/apt.15490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。